Post-traumatic stress disorder (PTSD) can arise following exposure to an exceptionally distressing event that surpasses the typical range of stressors. Such events, e.g. childhood trauma, violent personal assaults, natural or man-made disasters, accidents, combat, and various forms of violence, have the potential to trigger PTSD. It is worth noting that encounters with these events are not uncommon, with a lifetime prevalence of PTSD estimated at 6.8%.

National Center for PTSD Data

  • About 5 out of every 100 adults (or 5%) in the U.S. has PTSD in any given year. In 2020, about 13 million Americans had PTSD.
  • Women are more likely to develop PTSD than men. About 8 of every 100 women (or 8%) and 4 of every 100 men (or 4%) will have PTSD. This is in part due to the types of traumatic events that women are more likely to experience.
  • Veterans are more likely to have PTSD than civilians. Veterans who deployed to a war zone are also more likely to have PTSD than those who did not deploy.

In search for more options, numerous research trials and case reports have been supporting the innovative role of Ketamine infusion for the treatment of PTSD. For example, The American Journal of Psychiatry, which is is the official journal of the American Psychiatric Association published a randomized control trial in Jan 5, 2021. The results showed significantly positive response from Ketamine. 67% of participants in the ketamine group were treatment responders, compared with 20% in the controlled midazolam group. Among ketamine responders, the median time to loss of response was 27.5 days following the 2-week course of infusions. Ketamine infusions were well tolerated overall, without serious adverse events. Read more…

Are You Experiencing These Symptoms?

  • Frequent flashbacks and nightmares
  • Overreacting to something that reminds you of the traumatic event
  • Trouble maintaining daily task and relationships
  • Being easily upset or angry
  • physical manifestations such as pain, sweating, nausea or trembling, even anxiety

Watch A Real Story…

PTSD research at Icahn School of Medicine at Mount Sinai, New York